Best Practices for Managing Centralized Drug and Regimen Content
Streamlining Clinical Workflows
September 20, 2019
Best Practices for Managing Centralized Drug and Regimen Content - - PowerPoint PPT Presentation
September 20, 2019 Best Practices for Managing Centralized Drug and Regimen Content Streamlining Clinical Workflows Moderator Panelists Kyle Ritter PharmD, BCPS, BCOP place photo over circle Clinical Product & Content Specialist,
September 20, 2019
place photo over circle
Clinical Product & Content Specialist, Flatiron Health
Panelists Moderator
Lynette Garcia RN BSN, OCN Clinical Services Director, New Mexico Oncology Hematology Consultants LTD/ New Mexico Cancer Center Jonas Congelli, RPh Chief of Pharmacy, Laboratory & Nutrition Services, Hematology Oncology Associates of Central New York
Panelists
formulary and NCCN regimen library
10 MINUTES
from our community
25 MINUTES
10 MINUTES
Panelists
Panelists
therapies and newly approved drugs, especially in oncology. especially in oncology. Clinical teams face an ever-evolving landscape of
Integration with First Databank, a nationally recognized drug database, provides direct access to drug content The formulary list in OncoEMR is a tool to find, build, and manage drug-related information Each practice customizes and maintains their formulary
Clinical Oncology team converts NCCN order templates into OncoEMR regimens and reviews internally for quality assurance NCCN team reviews and approves all content to ensure accuracy Clinical Oncology team publishes content to all
cover all NCCN diseases over time
Access real-time support from Flatiron experts on products and services Attend live training sessions to learn about best practices and commonly requested topics Discover and explore curated “Tips and Tricks” to optimize practice workflows Open: Friday - 1-3:45pm Saturday - 7:45am-1pm; 2:45pm-5:45pm Sunday - 9am-12pm
Today, 2:30 to 4:00 PM at the Clinical Oncology Booths
and an ASCO QOPI certified practice
Panelists
Panelists
Available: Winter
NCCN Regimens Available Today
1. Anal carcinoma 2. Diffuse Large B-Cell Lymphoma 3. Follicular Lymphoma 4. Bladder Cancer 5. Breast Cancer 6. Colon Cancer 7. Cutaneous Melanoma 8. Kidney Cancer 9. Malignant Pleural Mesothelioma 10. Myelodysplastic Syndromes 11. Non-Small Cell Lung Cancer 12. Pancreatic Cancer 13. Prostate Cancer 14. Rectal Cancer 15. Small Cell Lung Cancer 16. Hepatobiliary Cancer 17. Ovarian cancers 18. Testicular Cancer